Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v21-FR Version v7-EN
Language French English
Date Updated 2018-02-08 2017-06-06
Drug Identification Number 02230418 02230418
Brand name IMITREX NASAL SPRAY IMITREX NASAL SPRAY
Common or Proper name Sumatriptan nasal spray Sumatriptan nasal spray
Company Name GLAXOSMITHKLINE INC GLAXOSMITHKLINE INC
Ingredients SUMATRIPTAN SUMATRIPTAN
Strength(s) 5MG 5MG
Dosage form(s) SPRAY SPRAY
Route of administration NASAL NASAL
Packaging size 2's 2's
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for shortage Shortage of an active ingredient. Shortage of an active ingredient.
Anticipated start date 2017-06-16
Actual start date 2017-06-12
Estimated end date 2018-02-09 Unknown
Actual end date 2018-02-07
Shortage status Resolved Anticipated shortage
Company comments
Health Canada comments